Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Oct;74(1):87–93.

IL-2 production in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.

K Oen 1, R Warrington 1, A M Rosenberg 1, D Krzekotowska 1
PMCID: PMC1541695  PMID: 2975541

Abstract

Interleukin 2 (IL-2) production in the CD4/non-T cell autologous mixed lymphocyte reaction (AMLR) was estimated for patients with juvenile rheumatoid arthritis (JRA). A cellular IL-2 assay (CILA) consisting of co-cultures of indicator cells, CTLL-2, added to CD4/non-T cell AMLR cultures was used. As both CD4 and CTLL-2 cell proliferation are IL-2 dependent, results of the CILA assay were taken as a reflection of the total IL-2 in the co-culture. By this assay most patients with JRA had normal IL-2 production. However, five patients with polyarticular disease had both a low AMLR and low levels of IL-2 production. Three of those tested showed little improvement in the AMLR on addition of recombinant IL-2, suggesting decreased responsiveness to IL-2 as well.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brewer E. J., Giannini E. H., Kuzmina N., Alekseev L. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. N Engl J Med. 1986 May 15;314(20):1269–1276. doi: 10.1056/NEJM198605153142001. [DOI] [PubMed] [Google Scholar]
  2. Brewer E. J., Jr, Bass J., Baum J., Cassidy J. T., Fink C., Jacobs J., Hanson V., Levinson J. E., Schaller J., Stillman J. S. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum. 1977 Mar;20(2 Suppl):195–199. [PubMed] [Google Scholar]
  3. Buchan G., Barrett K., Fujita T., Taniguchi T., Maini R., Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma. Clin Exp Immunol. 1988 Feb;71(2):295–301. [PMC free article] [PubMed] [Google Scholar]
  4. Clouse K. A., Bach F. H., Orosz C. G. Detection of HSV-1-induced lymphokine production in human cells by a direct indicator cell addition assay. J Immunol. 1984 Jun;132(6):2961–2967. [PubMed] [Google Scholar]
  5. Gatenby P. A., Kansas G. S., Xian C. Y., Evans R. L., Engleman E. G. Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J Immunol. 1982 Nov;129(5):1997–2000. [PubMed] [Google Scholar]
  6. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  7. Gupta S. Autologous mixed lymphocyte reaction in health and disease states in man. Vox Sang. 1983;44(5):265–288. doi: 10.1111/j.1423-0410.1983.tb04483.x. [DOI] [PubMed] [Google Scholar]
  8. Huang Y. P., Miescher P. A., Zubler R. H. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J Immunol. 1986 Dec 1;137(11):3515–3520. [PubMed] [Google Scholar]
  9. Huber C., Merkenschlager M., Gattringer C., Royston I., Fink U., Braunsteiner H. Human autologous mixed lymphocyte reactivity is primarily specific for xenoprotein determinants adsorbed to antigen-presenting cells during rosette formation with sheep erythrocytes. J Exp Med. 1982 Apr 1;155(4):1222–1227. doi: 10.1084/jem.155.4.1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kansas G. S., Engleman E. G. Phenotypic identification of suppressor-effector, suppressor-amplifier and suppressor-inducer T cells of B cell differentiation in man. Eur J Immunol. 1987 Apr;17(4):453–457. doi: 10.1002/eji.1830170403. [DOI] [PubMed] [Google Scholar]
  11. Kansas G. S., Wood G. S., Fishwild D. M., Engleman E. G. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8. J Immunol. 1985 May;134(5):2995–3002. [PubMed] [Google Scholar]
  12. Kotani H., Takada S., Ueda Y., Murakawa Y., Suzuki N., Sakane T. Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions. Clin Exp Immunol. 1984 May;56(2):390–398. [PMC free article] [PubMed] [Google Scholar]
  13. McKenna R. M., Ofosu-Appiah W., Warrington R. J., Wilkins J. A. Interleukin 2 production and responsiveness in active and inactive rheumatoid arthritis. J Rheumatol. 1986 Feb;13(1):28–32. [PubMed] [Google Scholar]
  14. Miller J. J., 3rd, Olds L. C. Interleukin-2 production by lymphocytes from blood of children with arthritis is less suppressed than in systemic lupus or cystic fibrosis. J Rheumatol. 1987 Aug;14(4):736–739. [PubMed] [Google Scholar]
  15. Miossec P., Kashiwado T., Ziff M. Inhibitor of interleukin-2 in rheumatoid synovial fluid. Arthritis Rheum. 1987 Feb;30(2):121–129. doi: 10.1002/art.1780300201. [DOI] [PubMed] [Google Scholar]
  16. Morimoto C., Letvin N. L., Distaso J. A., Aldrich W. R., Schlossman S. F. The isolation and characterization of the human suppressor inducer T cell subset. J Immunol. 1985 Mar;134(3):1508–1515. [PubMed] [Google Scholar]
  17. Oen K. Defects in pokeweed mitogen (PWM) induced immunoglobulin (Ig) synthesis by lymphocytes of patients with juvenile rheumatoid arthritis. J Rheumatol. 1985 Aug;12(4):728–734. [PubMed] [Google Scholar]
  18. Oen K., Krzekotowska D. Activation of OKT4 suppressor cells in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis. Clin Exp Immunol. 1987 Jul;69(1):57–67. [PMC free article] [PubMed] [Google Scholar]
  19. Palacios R., Möller G. HLA-DR antigens render resting T cells sensitive to interleukin-2 and induce production of the growth factor in the autologous mixed lymphocyte reaction. Cell Immunol. 1981 Sep 1;63(1):143–153. doi: 10.1016/0008-8749(81)90035-6. [DOI] [PubMed] [Google Scholar]
  20. Pope R. M., McChesney L., Talal N., Fischbach M. Characterization of the defective autologous mixed lymphocyte response in rheumatoid arthritis. Arthritis Rheum. 1984 Nov;27(11):1234–1244. doi: 10.1002/art.1780271105. [DOI] [PubMed] [Google Scholar]
  21. Reinherz E. L., Morimoto C., Fitzgerald K. A., Hussey R. E., Daley J. F., Schlossman S. F. Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol. 1982 Jan;128(1):463–468. [PubMed] [Google Scholar]
  22. Romain P. L., Morimoto C., Daley J. F., Palley L. S., Reinherz E. L., Schlossman S. F. Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction. Clin Immunol Immunopathol. 1984 Jan;30(1):117–128. doi: 10.1016/0090-1229(84)90012-6. [DOI] [PubMed] [Google Scholar]
  23. Sakane T., Kotani H., Takada S., Murakawa Y., Ueda Y. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function. J Immunol. 1983 Aug;131(2):753–761. [PubMed] [Google Scholar]
  24. Smolen J. S., Luger T. A., Chused T. M., Steinberg A. D. Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest. 1981 Dec;68(6):1601–1604. doi: 10.1172/JCI110416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Takada S., Ueda Y., Suzuki N., Murakawa Y., Hoshino T., Green I., Steinberg A. D., Horwitz D. A., Sakane T. Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2. Eur J Immunol. 1985 Mar;15(3):262–267. doi: 10.1002/eji.1830150310. [DOI] [PubMed] [Google Scholar]
  26. Takeuchi T., Schlossman S. F., Morimoto C. The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system. Cell Immunol. 1987 Jun;107(1):107–114. doi: 10.1016/0008-8749(87)90270-x. [DOI] [PubMed] [Google Scholar]
  27. Takeuchi T., Schlossman S. F., Morimoto C. The T4 molecule differentially regulating the activation of subpopulations of T4+ cells. J Immunol. 1987 Aug 1;139(3):665–671. [PubMed] [Google Scholar]
  28. Yu D. T., Chiorazzi N., Kunkel H. G. Helper factors derived from autologous mixed lymphocyte cultures. Cell Immunol. 1980 Mar 15;50(2):305–313. doi: 10.1016/0008-8749(80)90285-3. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES